MA55027A - Formulations plaisante au goût - Google Patents

Formulations plaisante au goût

Info

Publication number
MA55027A
MA55027A MA055027A MA55027A MA55027A MA 55027 A MA55027 A MA 55027A MA 055027 A MA055027 A MA 055027A MA 55027 A MA55027 A MA 55027A MA 55027 A MA55027 A MA 55027A
Authority
MA
Morocco
Prior art keywords
formulations
pleasant taste
pleasant
taste
taste formulations
Prior art date
Application number
MA055027A
Other languages
English (en)
Other versions
MA55027B1 (fr
Inventor
Atul Chhagan Badhan
Nicholas Finn Cunningham
Debendra Kumar Panda
Jeffrey Ellis Price
Paramjit Singh
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MA55027A publication Critical patent/MA55027A/fr
Publication of MA55027B1 publication Critical patent/MA55027B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA55027A 2019-02-20 2020-02-19 Formulations plaisante au goût MA55027B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962807871P 2019-02-20 2019-02-20
PCT/US2020/018762 WO2020172232A1 (fr) 2019-02-20 2020-02-19 Formulations plaisante au goût
EP20714040.1A EP3927315B1 (fr) 2019-02-20 2020-02-19 Formulations plaisante au goût

Publications (2)

Publication Number Publication Date
MA55027A true MA55027A (fr) 2021-12-29
MA55027B1 MA55027B1 (fr) 2026-02-27

Family

ID=69960719

Family Applications (1)

Application Number Title Priority Date Filing Date
MA55027A MA55027B1 (fr) 2019-02-20 2020-02-19 Formulations plaisante au goût

Country Status (26)

Country Link
US (1) US12115162B2 (fr)
EP (2) EP3927315B1 (fr)
JP (1) JP7442540B2 (fr)
KR (1) KR102715939B1 (fr)
CN (1) CN113438941A (fr)
AU (1) AU2020224102C1 (fr)
BR (1) BR112021016480A2 (fr)
CA (1) CA3127621C (fr)
CL (1) CL2021002192A1 (fr)
CO (1) CO2021010698A2 (fr)
DK (1) DK3927315T3 (fr)
EC (1) ECSP21059181A (fr)
ES (1) ES3059915T3 (fr)
FI (1) FI3927315T3 (fr)
HR (1) HRP20260053T1 (fr)
IL (1) IL285078B2 (fr)
LT (1) LT3927315T (fr)
MA (1) MA55027B1 (fr)
MX (1) MX2021010066A (fr)
PH (1) PH12021551859A1 (fr)
PL (1) PL3927315T3 (fr)
PT (1) PT3927315T (fr)
RS (1) RS67643B1 (fr)
UA (1) UA126843C2 (fr)
WO (1) WO2020172232A1 (fr)
ZA (1) ZA202105276B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
US20210068425A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions
EP4507694A1 (fr) * 2022-04-15 2025-02-19 KRKA, d.d., Novo mesto Forme pharmaceutique vétérinaire molle à mâcher
JP7355175B1 (ja) 2022-07-25 2023-10-03 フジテック株式会社 エレベータのブレーキ制動能力検査方法及びブレーキ制動能力検査装置
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
WO2024133631A1 (fr) * 2022-12-22 2024-06-27 Krka, D.D., Novo Mesto Composition vétérinaire contenant de l'oclacitinib
WO2024259191A2 (fr) * 2023-06-13 2024-12-19 Phoenix Biotechnology, Inc. Méthode et compositions pour le traitement de troubles cutanés
WO2025207585A1 (fr) * 2024-03-25 2025-10-02 Mccloud Josh Composition rodenticide activée par l'humidité sans danger pour l'environnement et système de distribution
CN120346171A (zh) * 2025-03-13 2025-07-22 湖南尚成生物科技有限公司 一种弗雷拉纳咀嚼片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique
WO2003000239A1 (fr) 2001-06-21 2003-01-03 Andrx Pharmaceuticals, Inc. Compositions pharmaceutiques stables a base de pravastatine
EP2314171B1 (fr) 2002-08-13 2019-11-13 Intervet International BV Compositions et procédé de fourniture d'un additif
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
RU2007149352A (ru) 2005-06-01 2009-07-20 Хилл`С Пет Ньютришн, Инк. (Us) Способы улучшения вкуса композиций для потребления животным
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
EP2063869B1 (fr) 2006-09-07 2014-03-05 Merial Ltd. Formulations antibiotiques vétérinaires sous forme mâchable tendre
CA2733359C (fr) 2008-08-20 2014-08-05 Pfizer Inc. Composes pyrrolo[2,3-d]pyrimidines
JP6290081B2 (ja) 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニＦｒｉｕｌｃｈｅｍ Ｓｐａ 動物への経口投与用組成物、その製造方法およびその使用
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US9532946B2 (en) * 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
PL3106150T3 (pl) 2013-12-04 2022-01-03 Boehringer Ingelheim Vetmedica Gmbh Ulepszone kompozycje farmaceutyczne pimobendanu
JP2017533959A (ja) 2014-11-03 2017-11-16 ゾエティス・サービシーズ・エルエルシー 嗜好性が高く咀嚼可能な獣医学的な組成物
US10434061B2 (en) 2014-12-05 2019-10-08 Societe Des Produits Nestle S.A. Composition and method for orally administering one or more active agents to a pet
WO2017106812A1 (fr) 2015-12-19 2017-06-22 First Time Us Generics Llc Formulations pharmaceutiques de comprimés mous à mâcher

Also Published As

Publication number Publication date
CO2021010698A2 (es) 2021-08-30
ECSP21059181A (es) 2021-11-30
CN113438941A (zh) 2021-09-24
AU2020224102C1 (en) 2023-03-16
MX2021010066A (es) 2021-09-21
ZA202105276B (en) 2025-04-30
AU2020224102B2 (en) 2022-09-08
CA3127621A1 (fr) 2020-08-27
FI3927315T3 (fi) 2026-01-20
EP3927315B1 (fr) 2025-11-26
PH12021551859A1 (en) 2022-05-30
US20220062287A1 (en) 2022-03-03
NZ779157A (en) 2023-10-27
US12115162B2 (en) 2024-10-15
RS67643B1 (sr) 2026-02-27
EP4710921A2 (fr) 2026-03-18
MA55027B1 (fr) 2026-02-27
KR20210114978A (ko) 2021-09-24
EP3927315A1 (fr) 2021-12-29
LT3927315T (lt) 2026-02-10
KR102715939B1 (ko) 2024-10-15
AU2020224102A1 (en) 2021-08-19
IL285078A (en) 2021-09-30
JP7442540B2 (ja) 2024-03-04
ES3059915T3 (en) 2026-03-24
BR112021016480A2 (pt) 2021-10-13
WO2020172232A1 (fr) 2020-08-27
JP2022521245A (ja) 2022-04-06
CA3127621C (fr) 2024-05-14
IL285078B1 (en) 2025-10-01
UA126843C2 (uk) 2023-02-08
CL2021002192A1 (es) 2022-04-01
PL3927315T3 (pl) 2026-03-16
PT3927315T (pt) 2026-01-29
DK3927315T3 (da) 2026-02-02
IL285078B2 (en) 2026-02-01
HRP20260053T1 (hr) 2026-02-27

Similar Documents

Publication Publication Date Title
MA55027A (fr) Formulations plaisante au goût
IL290034A (en) High concentration anti-c5 formulations
DK3846786T3 (da) Velsmagende antiparasitære formuleringer
EP3878518A4 (fr) Composition d'arôme
EP4081071C0 (fr) Fauteuil inclinable
IL285674A (en) Pharmaceutical formulations
DK3886820T3 (da) Kapselformuleringer
EP4013441A4 (fr) Formulations de larazotide
EP4176728A4 (fr) Chocolat
EP3871513A4 (fr) Composition orale au goût sucré rehaussé
DK3911298T3 (da) Formuleringer
EP3941414C0 (fr) Jouet de massage
EP3980697A4 (fr) Plaque chauffante améliorée
EP4284362A4 (fr) Préparations
PL3787596T3 (pl) Ulepszone formulacje farmaceutyczne
IL310652A (en) Formulations of radiprodil
EP4369940C0 (fr) Chocolat exempt de composants laitiers
EP4188088A4 (fr) Formulations
EP4175676A4 (fr) Formulations muco-pénétrantes
EP3941442A4 (fr) Formulations de supraparticules
HRP20260046T1 (hr) Oftalmološke formulacije
PL3795116T3 (pl) Proteza naczyniowa
HUE061722T2 (hu) Dezodorkészítmény
EP4397829A4 (fr) Clé
EP4009950A4 (fr) Formulations d'undécanoate de testostérone proliposomales